Treatment with BAT® [Botulism Antitoxin Heptavalent (Equine)] was associated with shorter hospital and intensive care unit stays.
The US Department of Health and Human Services (HHS) awarded a contract for $535 to Emergent BioSolutions Inc. for Vaccinia Immune Globulin Intravenous (VIGIV) to be used in the Strategic National Stockpile. VIGIV is the only therapeutic licensed by the US Food and Drug Administration (FDA) for the treatment of complications due to smallpox vaccination.
In a new study, remdesivir, an experimental antiviral drug, completely protected four African green monkeys from a lethal dose of Nipah virus,
Researchers say the discovery of a “hidden target” on the surface of the influenza A virus could lead to better ways to prevent and treat the flu.
Early Middle East respiratory syndrome (MERS) diagnosis may require more sensitive risk assessment tools to reduce delays related to patients and health system.
Researchers have developed a simple model that characterizes the biomechanics of Ebola virus-host cell adhesion, findings that could provide new and helpful information on the road to developing an effective Ebola treatment.
In a breakthrough with applicability across many flu strains, researchers find a potential small molecule that mimics antibodies to treat disease.
The development and ultimate approval of tecovirimat for the antiviral treatment of smallpox, a disease that has been eradicated from the world for nearly 40 years, required a unique regulatory approach based on the US Food and Drug Administration's Animal Rule.
A pharmaceutical company has developed a conventional drug that mimics the effect of antibodies that are effective against a wide range of flu viruses. Conventional drugs are cheaper and easier to make and store than antibodies and can be taken in pill form. The hope is that this antibody-mimicking strategy could lead to new treatments for many viral diseases.
This paper summarizes clinical syndromes and possible treatment options, for both developed and low-resource settings, and offer performance indicators and clinical metrics for case management.